FDA's new guidance and MOU with @​DeptVetAffairs on psychedelic drug development could open new doors for veterans battling PTSD. By supporting rigorous clinica

FDA's new guidance and MOU with @​DeptVetAffairs on psychedelic drug development could open new doors for veterans battling PTSD. By supporting rigorous clinical research into psychedelic therapies, we’re helping advance potentially transformative treatment options for those who've served our countr…